Results 131 to 140 of about 194,150 (247)

Prolactinomas in the transition from adolescence to young adulthood: A multicentre, retrospective study from the TALENT group

Journal of Neuroendocrinology, Volume 38, Issue 10, October 2026.
Abstract Prolactinomas in the transition age present unique challenges; treatment strategies and long‐term outcomes in this population remain incompletely characterised. This is a multicentre, retrospective study of 110 consecutive patients (33 males) with prolactinomas, aged 15–25 years, across five Italian referral centres (2010–2025).
Dario De Alcubierre, Claudia Giavoli, Tiziana Feola, Lorenzo Cerroni, Ludovica Vincenzi, Eriselda Profka, Aurora Pedroli, Giulia Puliani, Rosa Pirchio, Marta Tenuta, Renata S. Auriemma, Maria Luisa Appetecchia, Rosario Pivonello, Giovanna Mantovani, Andrea M. Isidori, Marie‐Lise Jaffrain‐Rea, Ashley Grossman, Emilia Sbardella   +17 more
wiley   +1 more source

Impact of MED12 mutation and CDK8 activity on uterine leiomyoma growth and response to gonadotropin-releasing hormone agonist treatment.

PLoS ONE
MED12 exon 2 mutation is the most frequent mutation associated with uterine leiomyomas. MED12 wild-type leiomyomas have a higher growth potential than mutant leiomyomas, suggesting that the mutation limits leiomyoma growth.
Saki Tanioka, Ryoko Asano, Yukihide Ota, Koichi Nagai, Katsuya Takenaka, Taichi Mizushima, Yohei Miyagi, Etsuko Miyagi   +7 more
doaj   +1 more source

Buserelin Improves Ovulation‐Embryo Synchrony Compared With hCG After eCG‐Induced Superovulation in Donor Sows

Reproduction in Domestic Animals, Volume 61, Issue S3, October 2026.
ABSTRACT This study directly compares hCG and buserelin as ovulation‐inducing agents following eCG‐based superovulation in weaned donor sows, focusing on their practical impact on ovulation‐embryo synchrony under field conditions. Fifty‐five multiparous sows received 1000 IU eCG 24 h after weaning and were treated at onset of estrus with either 750 IU ...
A. Lopez‐Jara, M. Garcia‐Canovas, H. Gonzalez‐Ramiro, M. A. Gil, C. Cuello, H. Rodriguez‐Martinez, I. Parrilla, E. A. Martinez   +7 more
wiley   +1 more source

Beyond canonical homeostasis: Dynamic, plastic, and intermittently unregulated physiology as the norm

Physiological Reports, Volume 14, Issue 20, October 2026.
Abstract Homeostasis is often taught as steady‐state regulation keeping internal variables within narrow limits—reflecting a mammalian bias. Yet, canonical homeostasis is far from universal. In many animals, including humans, normal physiological states allow some variables to fluctuate cyclically or stochastically while others remain tightly ...
Warren Burggren, Tobis Wang
wiley   +1 more source

COMBINED GNRH-AGONIST AND HMG THERAPY IN PATIENTS WITH STIMULATION FAILURE

, 1991
This study deals with the combined therapy of GnRH-agonist (GnRH-a) and HMG for stimulation in 15 patients who failed two prior in vitro fertilization attempts.
CREATSAS, G, LOUTRADIS, D, SISKOS, K, BLETSA, R, MICHALAS, S, KALLIANIDIS, K, ARAVANTINOS, D   +6 more
core  

Effects of the GnRH agonist leuprorelin on liver volume in premenopausal women with severe polycystic liver disease. [PDF]

Hepatol Commun
Wijbenga IG, Duijzer R, Geertsema P, Aapkes SE, Bais T, Messchendorp LA, Vart P, de Haas RJ, van den Berg M, Blokzijl H, Cantineau AEP, van Gastel MDA, Drenth JPH, Gansevoort DT.   +13 more
europepmc   +1 more source

Divergent Effects of GnRH Agonist and GnRH Antagonist Treatment on Platelet Activity and Transcriptome. [PDF]

JACC CardioOncol
Beitzen-Heineke A, Siskin M, Muller M, Bhatt A, Hafertepe KC, Xia Y, Economides M, Wise DR, Berger JS.   +8 more
europepmc   +1 more source

Does the recovery of serum FSH influence the ovarian sensitivity index in the follicular-phase depot GnRH agonist protocol? [PDF]

BMC Pregnancy Childbirth
Wang X, Zhu S, Fu K, Han Y, Chen X, Zhang C, Zhang Y.   +6 more
europepmc   +1 more source

Zayıf over cevaplı hastalarda ultra kısa GnRH agonist/antagonist protokolünün mikrodoz flare up protokolü ile karşılaştırılması

, 2010
Objective: To determine the potential effect of the ultrashort gonadotropin- releasing hormone (GnRH) agonist/GnRH antagonist protocol versus the microdose GnRH agonist protocol in poor responders undergoing intracytoplasmic sperm injection (ICSI ...
Şatıroğlu, Hakam, İltemir Duvan, Zehra Candan, Berker, Bülent, Kaya, Cemil, Aytaç, Ruşen   +4 more
core  

An injection-lite approach to ovarian stimulation in poor responder patients using corifollitropin alfa and nasal GnRH agonist. [PDF]

J Assist Reprod Genet
Arulpragasam K, Lieberman D, O'Neil M, Sweeten P, Dalati S, Shin JE, Tan J, Choi S, Briggs N, Barcelos I, Ledger W.   +10 more
europepmc   +1 more source